Literature DB >> 16643951

Cognitive impairment and decline in different MS subtypes.

Stephan C J Huijbregts1, Nynke F Kalkers, Leo M J de Sonneville, Vincent de Groot, Chris H Polman.   

Abstract

This paper presents results of two studies conducted to investigate cognition in different MS subtypes. First, the results of a study that has previously been published will be discussed. This was a cross-sectional study with 108 relapsing-remitting (RR), 71 secondary progressive (SP), 55 primary progressive (PP) MS patients, and 67 healthy controls [S.C.J. Huijbregts, N.F. Kalkers, L.M.J. de Sonneville, V. de Groot, I.E.W. Reuling, C.H. Polman, Differences in cognitive impairment of relapsing-remitting, secondary and primary progressive MS. Neurology 63 (2004) 335-339]. The second study involved a follow-up assessment after 2 years and included 30 SPMS patients, 25 PPMS patients, and 33 controls. The Brief Repeatable Battery of Neuropsychological Tests (BRB-N) was used for all cognitive assessments. All patient groups demonstrated cognitive deficits compared to healthy controls. RRMS patients were less affected compared to patients with progressive MS subtypes on the Paced Auditory Serial Addition Task (PASAT) and the Symbol Digit Modalities Test (SDMT). These differences were attenuated after control for physical disability level as measured by the Expanded Disability Status Scale. RRMS and SPMS patients were more severely impaired than PPMS patients on the 10/36 Spatial Recall Task and Word List Generation. Results of the follow-up study indicated that both progressive MS subtypes showed a lack of improvement compared to controls on the PASAT and the SDMT, but not on the other tasks of the BRB-N, indicating that performance on tasks requiring multiple abilities concurrently, i.e. visuo-spatial ability and processing speed (SDMT) or working memory and processing speed (PASAT), is most likely to decline across time.

Entities:  

Mesh:

Year:  2006        PMID: 16643951     DOI: 10.1016/j.jns.2005.07.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  35 in total

1.  Introducing demographic corrections for the 10/36 Spatial Recall Test.

Authors:  Adam Gerstenecker; Roy Martin; Daniel C Marson; Khurram Bashir; Kristen L Triebel
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-13       Impact factor: 3.485

2.  Subcutaneous Interferon Beta-1a Has a Positive Effect on Cognitive Performance in Mildly Disabled Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study.

Authors:  Francesco Patti; Maria Pia Amato; Stefano Bastianello; Luisa Caniatti; Elisabetta Di Monte; Fausto Lijoi; Benedetta Goretti; Silvia Messina; Orietta Picconi; Maria Rosalia Tola; Maria Trojano
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

3.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

4.  Systemic lipopolysaccharide administration impairs retrieval of context-object discrimination, but not spatial, memory: Evidence for selective disruption of specific hippocampus-dependent memory functions during acute neuroinflammation.

Authors:  Jennifer Czerniawski; Teiko Miyashita; Gail Lewandowski; John F Guzowski
Journal:  Brain Behav Immun       Date:  2014-10-19       Impact factor: 7.217

5.  Robust perfusion deficits in cognitively impaired patients with secondary-progressive multiple sclerosis.

Authors:  P L Francis; R Jakubovic; P O'Connor; L Zhang; A Eilaghi; L Lee; T J Carroll; J Mouannes-Srour; A Feinstein; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-14       Impact factor: 3.825

6.  MRI of the corpus callosum in multiple sclerosis: association with disability.

Authors:  A Ozturk; S A Smith; E M Gordon-Lipkin; D M Harrison; N Shiee; D L Pham; B S Caffo; P A Calabresi; D S Reich
Journal:  Mult Scler       Date:  2010-02       Impact factor: 6.312

7.  The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.

Authors:  D Obradovic; M Petrovic; I Antanasijevic; J Marinkovic; T Stojanovic; S Obradovic
Journal:  Neurol Sci       Date:  2012-05-03       Impact factor: 3.307

8.  Variations in functioning and disability in multiple sclerosis. A two-year prospective study.

Authors:  Charlotte Ytterberg; Sverker Johansson; Magnus Andersson; Lotta Widén Holmqvist; Lena von Koch
Journal:  J Neurol       Date:  2008-06-17       Impact factor: 4.849

9.  The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.

Authors:  Jelena Dackovic; Tatjana Pekmezovic; Sarlota Mesaros; Irena Dujmovic; Nebojsa Stojsavljevic; Vanja Martinovic; Jelena Drulovic
Journal:  Neurol Sci       Date:  2016-05-20       Impact factor: 3.307

10.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.

Authors:  Simone Migliore; Anna Ghazaryan; Ilaria Simonelli; Patrizio Pasqualetti; Doriana Landi; Maria Giuseppina Palmieri; Filomena Moffa; Pasquale Rinaldi; Fabrizio Vernieri; Maria Maddalena Filippi
Journal:  Neurol Sci       Date:  2016-04-20       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.